ConductScience.org, home

Paper11429233

Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.

Dwarkanath BS and 7 others. Int J Radiat Oncol Biol Phys, 2001. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Papers, record 11429233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11429233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
1.42
iCite
Revised in PubMed
2022-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dwarkanath BSB S
2Zolzer FF
3Chandana SS
4Bauch TT
5Adhikari JSJ S
6Muller WUW U
7Streffer CC
8Jain VV

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DeoxyglucoseMajor topic
Energy MetabolismMajor topic
NeoplasmsMajor topic
Adenosine Diphosphate
Adenosine Triphosphate
Carcinoma, Squamous Cell
DNA Damage
DNA Repair
Glioma
Glucose
Humans
Lactic Acid
Melanoma
Micronucleus Tests
Radiation Dosage
Radiobiology
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
41294814Radiation Without Borders: Unraveling Bystander and Non-Targeted Effects in Oncology.Cells2025https://conductscience.org/library/papers/41294814PubMed
39574178Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.Mol Cancer2024https://conductscience.org/library/papers/39574178PubMed
37206202An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanism.Bioeng Transl Med2023https://conductscience.org/library/papers/37206202PubMed
35414650The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.Lab Invest2022https://conductscience.org/library/papers/35414650PubMed
35216362Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways.Int J Mol Sci2022https://conductscience.org/library/papers/35216362PubMed
33834022Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy.Front Cell Dev Biol2021https://conductscience.org/library/papers/33834022PubMed
3339145218F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions.J Cancer2021https://conductscience.org/library/papers/33391452PubMed
33363507Metabolic Control of Epilepsy: A Promising Therapeutic Target for Epilepsy.Front Neurol2020https://conductscience.org/library/papers/33363507PubMed
319057452-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.Int J Mol Sci2019https://conductscience.org/library/papers/31905745PubMed
31517070Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation.Clin Transl Radiat Oncol2019https://conductscience.org/library/papers/31517070PubMed
30089593Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer.Lung Cancer2018https://conductscience.org/library/papers/30089593PubMed
29688867Role of metabolism in cancer cell radioresistance and radiosensitization methods.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/29688867PubMed
29617059Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.Cancer Sci2018https://conductscience.org/library/papers/29617059PubMed
28881665HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer.Oncotarget2017https://conductscience.org/library/papers/28881665PubMed
28191478Regulation of glycolysis in head and neck squamous cell carcinoma.Postdoc J2017https://conductscience.org/library/papers/28191478PubMed
26355636Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells.Breast Cancer (Dove Med Press)2015https://conductscience.org/library/papers/26355636PubMed
25925410Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells.BMC Cancer2015https://conductscience.org/library/papers/25925410PubMed
255472922-Deoxyglucose impairs Saccharomyces cerevisiae growth by stimulating Snf1-regulated and α-arrestin-mediated trafficking of hexose transporters 1 and 3.Mol Cell Biol2015https://conductscience.org/library/papers/25547292PubMed
25472878Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.Mol Cell Biochem2015https://conductscience.org/library/papers/25472878PubMed
25248151Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice.PLoS One2014https://conductscience.org/library/papers/25248151PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11429233

GET https://conductscience.org/api/papers/v1/11429233/cited_by?page=2